Helix BioPharma Corp. (TSX:HBP)
Canada · Delayed Price · Currency is CAD 1.840
0.00 (0.00%)
Feb 10, 2026, 2:29 PM EST
Helix BioPharma Market Cap
Helix BioPharma has a market cap or net worth of CAD 140.54 million as of February 11, 2026. Its market cap has increased by 186.68% in one year.
Market Cap
140.54M
Enterprise Value
140.39M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.84
Market Cap Chart
Since August 15, 1995, Helix BioPharma's market cap has increased from 9.38M to 140.54M, an increase of 1,397.71%. That is a compound annual growth rate of 9.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 140.54M | -22.36% |
| Dec 31, 2025 | 181.02M | 314.90% |
| Dec 31, 2024 | 43.63M | -4.12% |
| Dec 29, 2023 | 45.50M | 5.81% |
| Dec 30, 2022 | 43.00M | 0.61% |
| Dec 31, 2021 | 42.74M | -36.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 586.51M |
| NervGen Pharma | 426.12M |
| Satellos Bioscience | 312.50M |
| ME Therapeutics Holdings | 75.12M |
| Medicenna Therapeutics | 66.74M |
| Sharp Therapeutics | 66.17M |
| NurExone Biologic | 58.04M |
| Sernova Biotherapeutics | 49.17M |